Center-Authored Papers

Filters: Keyword is Probability  [Clear All Filters]
A
Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D et al..  1996.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.. JAMA : the journal of the American Medical Association. 276(22):1818-22. Abstract
B
Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diaconescu R, Woolfrey AE, Chauncey TR, Flowers MED, Mielcarek M et al..  2005.  Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(9):1993-2003. Abstract
C
Chlebowski RT, Anderson G, Manson JE, Pettinger M, Yasmeen S, Lane D, Langer RD, Hubbell AF, McTiernan A, Hendrix S et al..  2010.  Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(16):2690-7. Abstract
D
DeMartini WB, Kurland BF, Gutierrez RL, Blackmore CC, Peacock S, Lehman CD.  2011.  Probability of malignancy for lesions detected on breast MRI: a predictive model incorporating BI-RADS imaging features and patient characteristics.. European radiology. 21(8):1609-17. Abstract
Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH.  2000.  The uncertainty principle and industry-sponsored research.. Lancet. 356(9230):635-8. Abstract
F
Fero ML.  2008.  Doping: ignorance of basic statistics is all too common.. Nature. 455(7210):166.
Fesinmeyer MD, Mehta V, Tock L, Blough D, McDermott C, Ramsey SD.  2009.  Completion of radiotherapy for local and regional head and neck cancer in medicare.. Archives of otolaryngology--head & neck surgery. 135(9):860-7. Abstract
J
Jiao S, Bailey CP, Zhang S, Ladunga I.  2010.  Probabilistic peak calling and controlling false discovery rate estimations in transcription factor binding site mapping from ChIP-seq.. Methods in molecular biology (Clifton, N.J.). 674:161-77. Abstract
K
Khorana AA, Francis CW, Culakova E, Lyman GH.  2005.  Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.. Cancer. 104(12):2822-9. Abstract
L
Lara PN, Tangen CM, Conlon SJ, Flanigan RC, Crawford DE.  2009.  Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.. The Journal of urology. 181(2):512-6;discussion516-7. Abstract
LeBlanc M, Kooperberg C.  2010.  Boosting predictions of treatment success.. Proceedings of the National Academy of Sciences of the United States of America. 107(31):13559-60.
Lyman G, Lalla A, Barron R, Dubois RW.  2009.  Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States.. Current medical research and opinion. 25(2):401-11. Abstract
Lyman GH, Balducci L.  1993.  Overestimation of test effects in clinical judgment.. Journal of cancer education : the official journal of the American Association for Cancer Education. 8(4):297-307. Abstract
M
McCall-Hosenfeld JS, Freund KM, Legault C, Jaramillo SA, Cochrane BB, Manson JE, Wenger NK, Eaton CB, McNeeley GS, Rodriguez BL et al..  2008.  Sexual satisfaction and cardiovascular disease: the Women's Health Initiative.. The American journal of medicine. 121(4):295-301. Abstract
N
Ness RB, Albano JD, McTiernan A, Cauley JA.  2009.  Influence of estrogen plus testosterone supplementation on breast cancer.. Archives of internal medicine. 169(1):41-6. Abstract
P
Pepe MS, Feng Z, Longton G, Koopmeiners J.  2009.  Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility.. Statistics in medicine. 28(5):762-79. Abstract
R
Ramsey SD, Liu Z, Boer R, Sullivan SD, Malin J, Doan QV, Dubois RW, Lyman GH.  2009.  Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 12(2):217-25. Abstract
Reiner AP, Aragaki AK, Gray SL, Wactawski-Wende J, Cauley JA, Cochrane BB, Kooperberg C, Woods NF, LaCroix AZ.  2009.  Inflammation and thrombosis biomarkers and incident frailty in postmenopausal women.. The American journal of medicine. 122(10):947-54. Abstract
S
Stockl KM, Le L, Zakharyan A, Harada ASM, Solow BK, Addiego JE, Ramsey SD.  2010.  Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.. Archives of internal medicine. 170(8):704-10. Abstract
V
Vallejo-Torres L, Steuten L, Parkinson B, Girling AJ, Buxton MJ.  2011.  Integrating health economics into the product development cycle: a case study of absorbable pins for treating hallux valgus.. Medical decision making : an international journal of the Society for Medical Decision Making. 31(4):596-610. Abstract
W
Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, Storb R, Gopal AK.  2005.  Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(15):3439-46. Abstract
Y
Yanada M, Borthakur G, Ravandi F, Bueso-Ramos C, Kantarjian H, Estey E.  2008.  Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia.. Haematologica. 93(8):1263-5.
Yoo GH, Moon J, LeBlanc M, Lonardo F, Urba S, Kim H, Hanna E, Tsue T, Valentino J, Ensley J et al..  2009.  A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group. Archives of otolaryngology--head & neck surgery. 135(9):869-74. Abstract
Yu EY, Gulati R, Telesca D, Jiang P, Tam S, Russell KJ, Nelson PS, Etzioni R, Higano CS.  2010.  Duration of first off-treatment interval is prognostic for time to castration resistance and death in men with biochemical relapse of prostate cancer treated on a prospective trial of intermittent androgen deprivation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(16):2668-73. Abstract